247 related articles for article (PubMed ID: 33437055)
1. Cerebrospinal fluid metabolomics identifies 19 brain-related phenotype associations.
Panyard DJ; Kim KM; Darst BF; Deming YK; Zhong X; Wu Y; Kang H; Carlsson CM; Johnson SC; Asthana S; Engelman CD; Lu Q
Commun Biol; 2021 Jan; 4(1):63. PubMed ID: 33437055
[TBL] [Abstract][Full Text] [Related]
2. High-resolution metabolomic profiling of Alzheimer's disease in plasma.
Niedzwiecki MM; Walker DI; Howell JC; Watts KD; Jones DP; Miller GW; Hu WT
Ann Clin Transl Neurol; 2020 Jan; 7(1):36-45. PubMed ID: 31828981
[TBL] [Abstract][Full Text] [Related]
3. A global HILIC-MS approach to measure polar human cerebrospinal fluid metabolome: Exploring gender-associated variation in a cohort of elderly cognitively healthy subjects.
Gallart-Ayala H; Konz I; Mehl F; Teav T; Oikonomidi A; Peyratout G; van der Velpen V; Popp J; Ivanisevic J
Anal Chim Acta; 2018 Dec; 1037():327-337. PubMed ID: 30292309
[TBL] [Abstract][Full Text] [Related]
4. Quantitative trait loci mapping of circulating metabolites in cerebrospinal fluid to uncover biological mechanisms involved in brain-related phenotypes.
Reus LM; Boltz T; Francia M; Bot M; Ramesh N; Koromina M; Pijnenburg YAL; den Braber A; van der Flier WM; Visser PJ; van der Lee SJ; Tijms BM; Teunissen CE; Loohuis LO; Ophoff RA
bioRxiv; 2023 Sep; ():. PubMed ID: 37808647
[TBL] [Abstract][Full Text] [Related]
5. Elucidation of the complex metabolic profile of cerebrospinal fluid using an untargeted biochemical profiling assay.
Kennedy AD; Pappan KL; Donti TR; Evans AM; Wulff JE; Miller LAD; Reid Sutton V; Sun Q; Miller MJ; Elsea SH
Mol Genet Metab; 2017 Jun; 121(2):83-90. PubMed ID: 28412083
[TBL] [Abstract][Full Text] [Related]
6. An Integrated Bioinformatics Approach for Identifying Genetic Markers that Predict Cerebrospinal Fluid Biomarker p-tau181/Aβ1-42 Ratio in ApoE4-Negative Mild Cognitive Impairment Patients.
Sun Y; Bresell A; Rantalainen M; Höglund K; Lebouvier T; Salter H;
J Alzheimers Dis; 2015; 45(4):1061-76. PubMed ID: 25720397
[TBL] [Abstract][Full Text] [Related]
7. A Genome-Wide Association Study of α-Synuclein Levels in Cerebrospinal Fluid.
Zhong XL; Li JQ; Sun L; Li YQ; Wang HF; Cao XP; Tan CC; Wang L; Tan L; Yu JT;
Neurotox Res; 2019 Jan; 35(1):41-48. PubMed ID: 29959729
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
[TBL] [Abstract][Full Text] [Related]
9. Identification of altered metabolic pathways in plasma and CSF in mild cognitive impairment and Alzheimer's disease using metabolomics.
Trushina E; Dutta T; Persson XM; Mielke MM; Petersen RC
PLoS One; 2013; 8(5):e63644. PubMed ID: 23700429
[TBL] [Abstract][Full Text] [Related]
10. Accuracy of brain amyloid detection in clinical practice using cerebrospinal fluid β-amyloid 42: a cross-validation study against amyloid positron emission tomography.
Palmqvist S; Zetterberg H; Blennow K; Vestberg S; Andreasson U; Brooks DJ; Owenius R; Hägerström D; Wollmer P; Minthon L; Hansson O
JAMA Neurol; 2014 Oct; 71(10):1282-9. PubMed ID: 25155658
[TBL] [Abstract][Full Text] [Related]
11. Urinary metabolic phenotyping for Alzheimer's disease.
Kurbatova N; Garg M; Whiley L; Chekmeneva E; Jiménez B; Gómez-Romero M; Pearce J; Kimhofer T; D'Hondt E; Soininen H; Kłoszewska I; Mecocci P; Tsolaki M; Vellas B; Aarsland D; Nevado-Holgado A; Liu B; Snowden S; Proitsi P; Ashton NJ; Hye A; Legido-Quigley C; Lewis MR; Nicholson JK; Holmes E; Brazma A; Lovestone S
Sci Rep; 2020 Dec; 10(1):21745. PubMed ID: 33303834
[TBL] [Abstract][Full Text] [Related]
12. Effects of Alzheimer's disease-associated risk loci on cerebrospinal fluid biomarkers and disease progression: a polygenic risk score approach.
Martiskainen H; Helisalmi S; Viswanathan J; Kurki M; Hall A; Herukka SK; Sarajärvi T; Natunen T; Kurkinen KM; Huovinen J; Mäkinen P; Laitinen M; Koivisto AM; Mattila KM; Lehtimäki T; Remes AM; Leinonen V; Haapasalo A; Soininen H; Hiltunen M
J Alzheimers Dis; 2015; 43(2):565-73. PubMed ID: 25096612
[TBL] [Abstract][Full Text] [Related]
13. GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease.
Cruchaga C; Kauwe JS; Harari O; Jin SC; Cai Y; Karch CM; Benitez BA; Jeng AT; Skorupa T; Carrell D; Bertelsen S; Bailey M; McKean D; Shulman JM; De Jager PL; Chibnik L; Bennett DA; Arnold SE; Harold D; Sims R; Gerrish A; Williams J; Van Deerlin VM; Lee VM; Shaw LM; Trojanowski JQ; Haines JL; Mayeux R; Pericak-Vance MA; Farrer LA; Schellenberg GD; Peskind ER; Galasko D; Fagan AM; Holtzman DM; Morris JC; ; ; ; Goate AM
Neuron; 2013 Apr; 78(2):256-68. PubMed ID: 23562540
[TBL] [Abstract][Full Text] [Related]
14. The role of clusterin, complement receptor 1, and phosphatidylinositol binding clathrin assembly protein in Alzheimer disease risk and cerebrospinal fluid biomarker levels.
Schjeide BM; Schnack C; Lambert JC; Lill CM; Kirchheiner J; Tumani H; Otto M; Tanzi RE; Lehrach H; Amouyel P; von Arnim CA; Bertram L
Arch Gen Psychiatry; 2011 Feb; 68(2):207-13. PubMed ID: 21300948
[TBL] [Abstract][Full Text] [Related]
15. Identification of blood metabolites associated with risk of Alzheimer's disease by integrating genomics and metabolomics data.
Liu S; Zhong H; Zhu J; Wu L
Mol Psychiatry; 2024 Apr; 29(4):1153-1162. PubMed ID: 38216726
[TBL] [Abstract][Full Text] [Related]
16. Multielectrode array analysis of cerebrospinal fluid in Alzheimer's disease versus mild cognitive impairment: a potential diagnostic and treatment biomarker.
Görtz P; Siebler M; Ihl R; Henning U; Luckhaus C; Supprian T; Lange-Asschenfeldt C
Biochem Biophys Res Commun; 2013 May; 434(2):293-7. PubMed ID: 23541573
[TBL] [Abstract][Full Text] [Related]
17. The relevance of cerebrospinal fluid α-synuclein levels to sporadic and familial Alzheimer's disease.
Twohig D; Rodriguez-Vieitez E; Sando SB; Berge G; Lauridsen C; Møller I; Grøntvedt GR; Bråthen G; Patra K; Bu G; Benzinger TLS; Karch CM; Fagan A; Morris JC; Bateman RJ; Nordberg A; White LR; Nielsen HM;
Acta Neuropathol Commun; 2018 Nov; 6(1):130. PubMed ID: 30477568
[TBL] [Abstract][Full Text] [Related]
18. Genome-wide association reveals genetic effects on human Aβ42 and τ protein levels in cerebrospinal fluids: a case control study.
Han MR; Schellenberg GD; Wang LS;
BMC Neurol; 2010 Oct; 10():90. PubMed ID: 20932310
[TBL] [Abstract][Full Text] [Related]
19. Protocol for genome-wide association study of human blood metabolites.
Iwasaki T; Kamatani Y; Sonomura K; Kawaguchi S; Matsuda F
STAR Protoc; 2024 Jun; 5(2):103052. PubMed ID: 38700977
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
